FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anthony Ford

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Anthony P D W Ford; Debra A Cockayne
ATP and P2X purinoceptors in urinary tract disorders.
Timothy K Y Kaan; Ping K Yip; Sital Patel; Meirion Davies; Fabien Marchand; Debra A Cockayne; Philip A Nunn; Anthony H Dickenson; Anthony P D W Ford; Yu Zhong; Marzia Malcangio; Stephen B McMahon
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats.
Joel R Gever; Rothschild Soto; Robert A Henningsen; Renee S Martin; David H Hackos; Sandip Panicker; Werner Rubas; Ian B Oglesby; Michael P Dillon; Marcos E Milla; Geoffrey Burnstock; Anthony P D W Ford
AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anthony Ford (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Anthony P D W Ford; Debra A Cockayne
ATP and P2X purinoceptors in urinary tract disorders.
Handbook of experimental pharmacology 2011;(202):485-526.
2010: Timothy K Y Kaan; Ping K Yip; Sital Patel; Meirion Davies; Fabien Marchand; Debra A Cockayne; Philip A Nunn; Anthony H Dickenson; Anthony P D W Ford; Yu Zhong; Marzia Malcangio; Stephen B McMahon
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats.
Brain : a journal of neurology 2010;133(9):2549-64.
2010: Joel R Gever; Rothschild Soto; Robert A Henningsen; Renee S Martin; David H Hackos; Sandip Panicker; Werner Rubas; Ian B Oglesby; Michael P Dillon; Marcos E Milla; Geoffrey Burnstock; Anthony P D W Ford
AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.
British journal of pharmacology 2010;160(6):1387-98.
2010: Timothy K Y Kaan; Ping K Yip; John Grist; Joseph S Cefalu; Philip A Nunn; Anthony P D W Ford; Yu Zhong; Stephen McMahon
Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(12):4503-7.
2010: Birthe Schnegelsberg; Tung-Tien Sun; Gary Cain; Anindya Bhattacharya; Philip A Nunn; Anthony P D W Ford; Margaret A Vizzard; Debra A Cockayne
Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.
American journal of physiology. Regulatory, integrative and comparative physiology 2010;298(3):R534-47.
2010: Christine E Brotherton-Pleiss; Michael P Dillon; Anthony P D W Ford; Joel R Gever; David S Carter; Shelley K Gleason; Clara J Lin; Amy G Moore; Anthony W Thompson; Marzia Villa; Yansheng Zhai
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.
Bioorganic & medicinal chemistry letters 2010;20(3):1031-6.
2009: Joseph S Cefalu; Marlene A Guillon; Leah R Burbach; Quan-Ming Zhu; Dong-Qing Hu; Meghan J Ho; Anthony P D W Ford; Philip A Nunn; Debra A Cockayne
Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder.
The Journal of urology 2009;182(2):776-85.
2009: David S Carter; Muzaffar Alam; Haiying Cai; Michael P Dillon; Anthony P D W Ford; Joel R Gever; Alam Jahangir; Clara Lin; Amy G Moore; Paul J Wagner; Yansheng Zhai
Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
Bioorganic & medicinal chemistry letters 2009;19(6):1628-31.
2009: Alam Jahangir; Muzaffar Alam; David S Carter; Michael P Dillon; Daisy Joe Du Bois; Anthony P D W Ford; Joel R Gever; Clara Lin; Paul J Wagner; Yansheng Zhai; Jeff Zira
Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
Bioorganic & medicinal chemistry letters 2009;19(6):1632-5.
2008: Bikramjit Chopra; Joel Gever; Stacey R Barrick; Ann T Hanna-Mitchell; Jonathan M Beckel; Anthony P D W Ford; Lori A Birder
Expression and function of rat urothelial P2Y receptors.
American journal of physiology. Renal physiology 2008;294(4):F821-9.
2007: Joseph S Cefalu; Quan-Ming Zhu; Anne-Christin Eggers; Timothy K Y Kaan; Meghan J Ho; Mary-Frances Jett; Debra A Cockayne; Anthony P D W Ford; Philip A Nunn
Effects of the selective prostacyclin receptor antagonist RO3244019 on the micturition reflex in rats.
The Journal of urology 2007;178(6):2683-8.
2007: Mina Ryten; Rachel Koshi; Gillian E Knight; Mark Turmaine; P Dunn; Debra A Cockayne; Anthony P D W Ford; Geoffrey Burnstock
Abnormalities in neuromuscular junction structure and skeletal muscle function in mice lacking the P2X2 nucleotide receptor.
Neuroscience 2007;148(3):700-11.
2006: Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Pharmacology of P2X channels.
Pflügers Archiv : European journal of physiology 2006;452(5):513-37.
2006: Anthony P D W Ford; Joel R Gever; Philip A Nunn; Yu Zhong; Joseph S Cefalu; Michael P Dillon; Debra A Cockayne
Purinoceptors as therapeutic targets for lower urinary tract dysfunction.
British journal of pharmacology 2006;147 Suppl 2():S132-43.
2006: Keith R Bley; Anindya Bhattacharya; Donald V Daniels; Joel R Gever; Alam Jahangir; Counde O'Yang; Steven Smith; Dinesh Srinivasan; Anthony P D W Ford; Mary-Frances Jett
RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.
British journal of pharmacology 2006;147(3):335-45.
2005: Apostolos Apostolidis; Roshni Popat; Yiangos Yiangou; Debra A Cockayne; Anthony P D W Ford; J B Davis; Prokar Dasgupta; Clare J Fowler; Praveen Anand
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.
The Journal of urology 2005;174(3):977-82; discussion 982-3.
2005: Debra A Cockayne; Philip M Dunn; Yu Zhong; Weifang Rong; Sara G Hamilton; Gillian E Knight; Huai Zhen Ruan; Bei Ma; Ping Yip; Philip A Nunn; Stephen McMahon; Geoffrey Burnstock; Anthony P D W Ford
P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP.
The Journal of physiology 2005;567(Pt 2):621-39.
2005: S Jaime-Figueroa; R Greenhouse; Fernando Padilla; Michael P Dillon; Joel R Gever; Anthony P D W Ford
Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist.
Bioorganic & medicinal chemistry letters 2005;15(13):3292-5.
2005: Brian F King; Min Liu; Andrea Townsend-Nicholson; Jürg Pfister; Fernando Padilla; Anthony P D W Ford; Joel R Gever; Ian B Oglesby; Stephanie Schorge; Geoffrey Burnstock
Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red.
British journal of pharmacology 2005;145(3):313-22.
2005: Paul D Walden; Dorene Marinese; Dinesh Srinivasan; Elda Tzoumaka; Harley T Syyong; Anthony P D W Ford; Anindya Bhattacharya
Effect of neurokinins on canine prostate cell physiology.
The Prostate 2005;63(4):358-68.
2005: Robin D Clark; Alam Jahangir; Muzaffar Alam; Cynthia Rocha; Lin Lin; Bodil Bjorner; Khanh Nguyen; Carole Grady; Timothy J Williams; George Stepan; Hai Ming Tang; Anthony P D W Ford
Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modification.
Bioorganic & medicinal chemistry letters 2005;15(6):1697-700.
2005: Bikramjit Chopra; Stacey Barrick; Susan Meyers; Jonathan M Beckel; Mark L Zeidel; Anthony P D W Ford; william chesney de groat; Lori A Birder
Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium.
The Journal of physiology 2005;562(Pt 3):859-71.
2004: Dinesh Srinivasan; Alan H Kosaka; Donald V Daniels; Anthony P D W Ford; Anindya Bhattacharya
Pharmacological and functional characterization of bradykinin B2 receptor in human prostate.
European journal of pharmacology 2004;504(3):155-67.
2004: Lori A Birder; Huai Zhen Ruan; Bikramjit Chopra; Z Xiang; Stacey Barrick; Buffington Tony; James R Roppolo; Anthony P D W Ford; william chesney de groat; Geoffrey Burnstock
Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis.
American journal of physiology. Renal physiology 2004;287(5):F1084-91.
2004: Ciaran M Brady; Apostolos Apostolidis; Yiangos Yiangou; Preston A Baecker; Anthony P D W Ford; Alex Freeman; Thomas S Jacques; Clare J Fowler; Praveen Anand
P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin.
European urology 2004;46(2):247-53.
2004: Anindya Bhattacharya; Hong Dang; Quan-Ming Zhu; Birthe Schnegelsberg; Nora Rozengurt; Gary Cain; Rachelle Prantil; David A Vorp; Nicholas Guy; David Julius; Anthony P D W Ford; Henry A Lester; Debra A Cockayne
Uropathic observations in mice expressing a constitutively active point mutation in the 5-HT3A receptor subunit.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(24):5537-48.
2004: Bei Ma; Huai Zhen Ruan; Debra A Cockayne; Anthony P D W Ford; Geoffrey Burnstock; Philip M Dunn
Identification of P2X receptors in cultured mouse and rat parasympathetic otic ganglion neurones including P2X knockout studies.
Neuropharmacology 2004;46(7):1039-48.
2004: Dinesh Srinivasan; Leah R Burbach; Donald V Daniels; Anthony P D W Ford; Anindya Bhattacharya
Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
British journal of pharmacology 2004;142(2):297-304.
2004: Apostolos Apostolidis; Yiangos Yiangou; Ciaran M Brady; Anthony P D W Ford; Preston A Baecker; Thomas S Jacques; Alex Freeman; Clare J Fowler; Praveen Anand
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxin.
BJU international 2004;93(3):336-40.
2004: DR Blue; Donald V Daniels; Joel R Gever; Mary-Frances Jett; Counde O'Yang; H M Tang; TJ Williams; Anthony P D W Ford
Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence.
BJU international 2004;93(1):162-70.
2004: D M Musselman; Anthony P D W Ford; D J Gennevois; M L Harbison; A L Laurent; A S Mokatrin; R R Stoltz; DR Blue
A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
BJU international 2004;93(1):78-83.
2003: Weifang Rong; Alexander V Gourine; Debra A Cockayne; Zhenghua Xiang; Anthony P D W Ford; K Michael Spyer; Geoffrey Burnstock
Pivotal role of nucleotide P2X2 receptor subunit of the ATP-gated ion channel mediating ventilatory responses to hypoxia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(36):11315-21.
2003: Jianhua Ren; Xiaochun Bian; Matthew DeVries; Birthe Schnegelsberg; Debra A Cockayne; Anthony P D W Ford; James J Galligan
P2X2 subunits contribute to fast synaptic excitation in myenteric neurons of the mouse small intestine.
The Journal of physiology 2003;552(Pt 3):809-21.
2003: Xiaochun Bian; Jianhua Ren; Matthew DeVries; Birthe Schnegelsberg; Debra A Cockayne; Anthony P D W Ford; James J Galligan
Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit.
The Journal of physiology 2003;551(Pt 1):309-22.
2003: F J Lopez; L Arias; R Chan; DE Clarke; TR Elworthy; Anthony P D W Ford; A Guzman; S Jaime-Figueroa; JR Jasper; DJ Morgans; Fernando Padilla; A Perez-Medrano; C Quintero; M Romero; L Sandoval; S A Smith; TJ Williams; DR Blue
Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.
Bioorganic & medicinal chemistry letters 2003;13(11):1873-8.
2003: Gillian C Bennett; Anthony P D W Ford; Jacqueline A M Smith; Caroline J Emmett; Tania E Webb; Michael R Boarder
P2Y receptor regulation of cultured rat cerebral cortical cells: calcium responses and mRNA expression in neurons and glia.
British journal of pharmacology 2003;139(2):279-88.
2003: Tara Renton; Yiangos Yiangou; Preston A Baecker; Anthony P D W Ford; Praveen Anand
Capsaicin receptor VR1 and ATP purinoceptor P2X3 in painful and nonpainful human tooth pulp.
Journal of orofacial pain 2003;17(3):245-50.
2003: Y Zhong; A S Banning; Debra A Cockayne; Anthony P D W Ford; G Burnstock; Stephen McMahon
Bladder and cutaneous sensory neurons of the rat express different functional P2X receptors.
Neuroscience 2003;120(3):667-75.
2002: Barry A O'Reilly; Alan H Kosaka; Gillian F Knight; Thomas K Chang; Anthony P D W Ford; Janice M Rymer; Rick Popert; Geoffrey Burnstock; Stephen McMahon
P2X receptors and their role in female idiopathic detrusor instability.
The Journal of urology 2002;167(1):157-64.
2001: Y Zhong; Philip M Dunn; M Bardini; Anthony P D W Ford; Debra A Cockayne; Geoffrey Burnstock
Changes in P2X receptor responses of sensory neurons from P2X3-deficient mice.
The European journal of neuroscience 2001;14(11):1784-92.
2001: Paul Facer; CH Knowles; P K Tam; Anthony P D W Ford; N Dyer; Preston A Baecker; Praveen Anand
Novel capsaicin (VR1) and purinergic (P2X3) receptors in Hirschsprung's intestine.
Journal of pediatric surgery 2001;36(11):1679-84.
2001: Yiangos Yiangou; Paul Facer; Preston A Baecker; Anthony P D W Ford; CH Knowles; C L H Chan; Norman S Williams; Praveen Anand
ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2001;13(4):365-9.
2001: Mila Vlaskovska; Lubomir Kasakov; Weifang Rong; P Bodin; M Bardini; Debra A Cockayne; Anthony P D W Ford; Geoffrey Burnstock
P2X3 knock-out mice reveal a major sensory role for urothelially released ATP.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(15):5670-7.
2001: Barry A O'Reilly; Alan H Kosaka; Thomas K Chang; Anthony P D W Ford; Rick Popert; Stephen McMahon
A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction.
BJU international 2001;87(7):617-22.
2001: Barry A O'Reilly; Alan H Kosaka; Thomas K Chang; Anthony P D W Ford; Rick Popert; J M Rymer; Stephen McMahon
A quantitative analysis of purinoceptor expression in human fetal and adult bladders.
The Journal of urology 2001;165(5):1730-4.
2001: T D Meloy; Donald V Daniels; SS Hegde; Richard M Eglen; Anthony P D W Ford
Functional characterization of rat submaxillary gland muscarinic receptors using microphysiometry.
British journal of pharmacology 2001;132(7):1606-14.
2000: Debra A Cockayne; S G Hamilton; Quan-Ming Zhu; Philip M Dunn; Y Zhong; SD Novakovic; A B Malmberg; G Cain; A Berson; LC Kassotakis; LR Hedley; WG Lachnit; G Burnstock; Stephen McMahon; Anthony P D W Ford
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice.
Nature 2000;407(6807):1011-5.
2000: WG Lachnit; Ian B Oglesby; Joel R Gever; M Gever; C Huang; X C Li; H Jin; J G McGivern; Anthony P D W Ford
Regulated expression of the rat recombinant P2X(3) receptor in stably transfected CHO-K1 tTA cells.
Journal of the autonomic nervous system 2000;81(1-3):75-81.
1999: N Watson; Donald V Daniels; Anthony P D W Ford; Richard M Eglen; SS Hegde
Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.
British journal of pharmacology 1999;127(2):590-6.
1999: TJ Williams; DR Blue; Donald V Daniels; B Davis; TR Elworthy; Joel R Gever; MS Kava; DJ Morgans; Fernando Padilla; S Tassa; RL Vimont; Christopher Chapple; R Chess-Williams; Richard M Eglen; DE Clarke; Anthony P D W Ford
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
British journal of pharmacology 1999;127(1):252-8.
1999: Donald V Daniels; Joel R Gever; JR Jasper; MS Kava; JD Lesnick; T D Meloy; G Stepan; TJ Williams; DE Clarke; DJ Chang; Anthony P D W Ford
Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies.
European journal of pharmacology 1999;370(3):337-43.
1999: SD Novakovic; LC Kassotakis; Ian B Oglesby; J A Smith; Richard M Eglen; Anthony P D W Ford; John C Hunter
Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury.
Pain 1999;80(1-2):273-82.
1998: SS Hegde; D A Mandel; M R Wilford; S Briaud; Anthony P D W Ford; Richard M Eglen
Evidence for purinergic neurotransmission in the urinary bladder of pithed rats.
European journal of pharmacology 1998;349(1):75-82.
1998: MS Kava; DR Blue; RL Vimont; DE Clarke; Anthony P D W Ford
Alpha1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man.
British journal of pharmacology 1998;123(7):1359-66.
1998: Choong M Chan; Robert J Unwin; M Bardini; Ian B Oglesby; Anthony P D W Ford; Andrea Townsend-Nicholson; Geoffrey Burnstock
Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys.
The American journal of physiology 1998;274(4 Pt 2):F799-804.
1998: DJ Chang; Thomas K Chang; S S Yamanishi; F H Salazar; Alan H Kosaka; R Khare; S Bhakta; JR Jasper; I S Shieh; JD Lesnick; Anthony P D W Ford; Donald V Daniels; Richard M Eglen; DE Clarke; C Bach; H W Chan
Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms.
FEBS letters 1998;422(2):279-83.
1998: Martin C Michel; K Taguchi; R S Schäfers; TJ Williams; DE Clarke; Anthony P D W Ford
Alpha 1-adrenoceptor subtypes in the human cardiovascular and urogenital systems.
Advances in pharmacology (San Diego, Calif.) 1998;42():394-8.
1997: TR Elworthy; Anthony P D W Ford; G W Bantle; DJ Morgans; R S Ozer; W S Palmer; D B Repke; M Romero; L Sandoval; E B Sjogren; F X Talamás; A Vazquez; H Wu; N F Arredondo; DR Blue; A DeSousa; L M Gross; MS Kava; JD Lesnick; RL Vimont; TJ Williams; Quan-Ming Zhu; J R Pfister; DE Clarke
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists.
Journal of medicinal chemistry 1997;40(17):2674-87.
1997: Anthony P D W Ford; Donald V Daniels; DJ Chang; Joel R Gever; JR Jasper; JD Lesnick; DE Clarke
Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
British journal of pharmacology 1997;121(6):1127-35.
1997: WG Lachnit; A M Tran; DE Clarke; Anthony P D W Ford
Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat.
British journal of pharmacology 1997;120(5):819-26.
1996: W G Lachnit; Anthony P D W Ford; DE Clarke
SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties.
European journal of pharmacology 1996;297(1-2):83-6.
1996: Anthony P D W Ford; N F Arredondo; DR Blue; D W Bonhaus; JR Jasper; MS Kava; JD Lesnick; J R Pfister; I A Shieh; R L Vimont; TJ Williams; J E McNeal; T A Stamey; DE Clarke
RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.
Molecular pharmacology 1996;49(2):209-15.
1995: DR Blue; D W Bonhaus; Anthony P D W Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; TJ Williams; DE Clarke
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.
British journal of pharmacology 1995;115(2):283-94.
1994: Anthony P D W Ford; T J Williams; DR Blue; DE Clarke
Alpha 1-adrenoceptor classification: sharpening Occam's razor.
Trends in pharmacological sciences 1994;15(6):167-70.
1994: M V Waikar; Anthony P D W Ford; DE Clarke
Evidence for an inhibitory 5-HT4 receptor in urinary bladder of rhesus and Cynomolgus monkeys.
British journal of pharmacology 1994;111(1):213-8.
1993: Anthony P D W Ford; DE Clarke
The 5-HT4 receptor.
Medicinal research reviews 1993;13(6):633-62.
1993: M V Waikar; SS Hegde; Anthony P D W Ford; DE Clarke
Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
The Journal of pharmacology and experimental therapeutics 1993;264(2):654-61.
1992: Richard M Eglen; G C Harris; Anthony P D W Ford; E H Wong; J R Pfister; R L Whiting
The action of (+/-)L-660,863 [(+/-)3-(3-amino-1,2,4-oxadiazole-5-yl)-quinuclidine] at muscarinic receptor subtypes in vitro.
Naunyn-Schmiedeberg's archives of pharmacology 1992;345(4):375-81.
1992: Anthony P D W Ford; Richard M Eglen; R L Whiting
Analysis of muscarinic cholinoceptors mediating phosphoinositide hydrolysis in guinea pig cardiac muscle.
European journal of pharmacology 1992;225(2):105-12.
1992: Anthony P D W Ford; G S Baxter; Richard M Eglen; DE Clarke
5-Hydroxytryptamine stimulates cyclic AMP formation in the tunica muscularis mucosae of the rat oesophagus via 5-HT4 receptors.
European journal of pharmacology 1992;211(1):117-20.